Reny JL - Search Results

1

Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management.

Reny JL, Bonvini RF, Bonvini JM, Roffi M, Fontana P. Reny JL, et al. Cardiovasc Ther. 2012 Feb;30(1):e41-50. doi: 10.1111/j.1755-5922.2010.00248.x. Epub 2010 Nov 14. Cardiovasc Ther. 2012. PMID: 21073667 Free article. Review.

2

Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.

Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P. Fontana P, et al. Among authors: reny jl. Circulation. 2003 Aug 26;108(8):989-95. doi: 10.1161/01.CIR.0000085073.69189.88. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912815

3

[Haemostasis. Aspirin and clopidogrel platelet resistances].

Fontana P, Berdagué P, Reny JL. Fontana P, et al. Among authors: reny jl. Rev Med Suisse. 2006 Jan 4;2(47):25-9. Rev Med Suisse. 2006. PMID: 16465941 Review. French.

4

Laboratory-defined aspirin resistance and recurrent cardiovascular events.

Fontana P, Reny JL. Fontana P, et al. Among authors: reny jl. Arch Intern Med. 2008 Mar 10;168(5):549-50. doi: 10.1001/archinte.168.5.549. Arch Intern Med. 2008. PMID: 18332305 No abstract available.

5

[Frequently asked questions on clopidogrel treatment: indications, resistance, and biological evaluation in vascular patients].

Fontana P, Reny JL. Fontana P, et al. Among authors: reny jl. Rev Med Suisse. 2008 Feb 6;4(143):360-3. Rev Med Suisse. 2008. PMID: 18386673 Review. French.

6

Aspirin response variability assessed with the PFA-100 device.

Reny JL, Quéré I, de Moerloose P, Fontana P. Reny JL, et al. Thromb Haemost. 2008 May;99(5):968-9; author reply 969. doi: 10.1160/TH08-02-0123. Thromb Haemost. 2008. PMID: 18449432 No abstract available.

7

Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance.

Bonvini RF, Reny JL, Mach F, Zeller T, Fontana P. Bonvini RF, et al. Among authors: reny jl. Curr Vasc Pharmacol. 2009 Apr;7(2):198-208. doi: 10.2174/157016109787455662. Curr Vasc Pharmacol. 2009. PMID: 19356003 Review.

8

Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis.

Combescure C, Fontana P, Mallouk N, Berdague P, Labruyere C, Barazer I, Gris JC, Laporte S, Fabbro-Peray P, Reny JL; CLOpidogrel and Vascular ISchemic Events Meta-analysis Study Group. Combescure C, et al. Among authors: reny jl. J Thromb Haemost. 2010 May;8(5):923-33. doi: 10.1111/j.1538-7836.2010.03809.x. Epub 2010 Feb 12. J Thromb Haemost. 2010. PMID: 20156305 Free article. Review.

9

[Evaluating the biological efficacy of clopidogrel: genotype or phenotype?].

Fontana P, Bonvini RF, Roffi M, Boehlen F, Reber G, de Moerloose P, Reny JL. Fontana P, et al. Among authors: reny jl. Rev Med Suisse. 2010 Feb 10;6(235):302-5. Rev Med Suisse. 2010. PMID: 20218180 French.

10

Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients.

Zufferey A, Reny JL, Combescure C, de Moerloose P, Sanchez JC, Fontana P. Zufferey A, et al. Among authors: reny jl. Thromb Haemost. 2011 Sep;106(3):466-74. doi: 10.1160/TH11-04-0226. Epub 2011 Jul 4. Thromb Haemost. 2011. PMID: 21725581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters